Epigenetic Changes in Basal Cell Carcinoma Affect SHH and WNT Signaling Components
Author(s) -
Tjinta Brinkhuizen,
Karin van den Hurk,
Véronique Winnepenninckx,
Joep P. de Hoon,
Ariënne M. van Marion,
Jürgen Veeck,
Ma van Engeland,
Maurice A. M. Van Steensel
Publication year - 2012
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0051710
Subject(s) - wnt signaling pathway , dna methylation , biology , epigenetics , adenomatous polyposis coli , carcinogenesis , cancer research , methylation , basal cell carcinoma , microbiology and biotechnology , genetics , gene , gene expression , pathology , cancer , medicine , colorectal cancer , basal cell
Background The genetic background of Basal Cell Carcinoma (BCC) has been studied extensively, while its epigenetic makeup has received comparatively little attention. Epigenetic alterations such as promoter hypermethylation silence tumor suppressor genes (TSG) in several malignancies. Objective We sought to analyze the promoter methylation status of ten putative (tumor suppressor) genes that are associated with Sonic Hedgehog (SHH), WNT signaling and (hair follicle) tumors in a large series of 112 BCC and 124 healthy control samples by methylation-specific PCR. Results Gene promoters of SHH (P = 0.016), adenomatous polyposis coli ( APC ) (P = 0.003), secreted frizzled-related protein 5 ( SFRP5 ) (P = 0.004) and Ras association domain family 1A ( RASSF1A ) (P = 0.023) showed significantly more methylation in BCC versus normal skin. mRNA levels of these four genes were reduced for APC and SFRP5 in BCC (n = 6) vs normal skin (n = 6). Down regulation of SHH, APC and RASSF1A could be confirmed on protein level as well (P<0.001 for all genes) by immunohistochemical staining. Increased canonical WNT activity was visualized by β-catenin staining, showing nuclear β-catenin in only 28/101 (27.7%) of BCC. Absence of nuclear β-catenin in some samples may be due to high levels of membranous E-cadherin (in 94.1% of the samples). Conclusions We provide evidence that promoter hypermethylation of key players within the SHH and WNT pathways is frequent in BCC, consistent with their known constitutive activation in BCC. Epigenetic gene silencing putatively contributes to BCC tumorigenesis, indicating new venues for treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom